THAR

8-K - Canton Strategic Holdings, Inc. (0001861657) (Filer)

New NASDAQ Ticker Symbol "CNTN" to Begin Trading February 18, 2026Company Positioned to Support Institutional Adoption of First Privacy-Enabled Public Blockchain Processing $9 Trillion in Monthly Transaction VolumeNEW YORK, Feb. 17, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ:THAR) (the "Company") the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today announced the launch of a corporate rebrand in alignment with its digital asset treasury strategy. Effective Wednesday, February 18, 2026, the Company will change its name to Canton Strategic Holdings, Inc. In connection with the name change, the commo

3 - Tharimmune, Inc. (0001861657) (Issuer)

3 - Tharimmune, Inc. (0001861657) (Issuer)

3 - Tharimmune, Inc. (0001861657) (Issuer)

3 - Tharimmune, Inc. (0001861657) (Issuer)

SCHEDULE 13G - Tharimmune, Inc. (0001861657) (Subject)

8-K - Tharimmune, Inc. (0001861657) (Filer)

Leadership Expansion Supports Execution of Canton Network Infrastructure Strategy Former DRW and Citadel Leader Joins as COO to Drive Institutional Platform Expansion NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced that its Board of Directors (the "Board") has elected Mark Wendland, Chief Executive Officer, as Chairman of the Board and approved the appointment of Angela Radkowski as Chief Operating Officer, effective February 5, 2026. Mr. Wendland succeeds Vincent LoPriore, wh

SCHEDULE 13G - Tharimmune, Inc. (0001861657) (Subject)

SCHEDULE 13G - Tharimmune, Inc. (0001861657) (Subject)

8-K - Tharimmune, Inc. (0001861657) (Filer)

New Directors Strengthen Governance as Company Advances Canton Network Infrastructure Former CFTC Commissioner Jill Sommers Brings Decades of Regulatory and Public Policy Experience DRW Chief of Staff William Wiley, CFA, Adds Extensive Leadership Experience Across Capital Markets and Global Operations NEW YORK, Feb. 2, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced that its Board of Directors (the "Board") has elected Jill Sommers and William Wiley, CFA, to the Board, effective February 1, 20

DEFA14A - Tharimmune, Inc. (0001861657) (Filer)

8-K - Tharimmune, Inc. (0001861657) (Filer)

8-K - Tharimmune, Inc. (0001861657) (Filer)

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ:THAR), the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today announced the closing of its previously announced underwritten registered direct offering which included the issuance of 1,800,000 shares of its common stock at a price of $2.92 per share and pre-funded warrants to purchase up to 17,000,000 shares of common stock at a price of $2.9199 per pre-funded warrant. The gross proceeds to the Company from the offering are approximately $55 million, before deducting underwriting discounts and commissions and other offering expenses pay

8-K - Tharimmune, Inc. (0001861657) (Filer)

424B5 - Tharimmune, Inc. (0001861657) (Filer)

NEW YORK, Jan. 20, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ:THAR), the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today announced the pricing of a $55 million registered offering. Tharimmune, Inc. operates a differentiated digital asset treasury strategy by actively participating in the Canton Network – a privacy-enabled, secure blockchain hosting trillions in assets on chain. The offering is expected to close on or about January 21, 2026, subject to the satisfaction of customary closing conditions. The transaction includes the issuance of 1,800,000 shares of its common stock at a price of $2.

EFFECT - Tharimmune, Inc. (0001861657) (Filer)

DEF 14A - Tharimmune, Inc. (0001861657) (Filer)

8-K - Tharimmune, Inc. (0001861657) (Filer)

S-3 - Tharimmune, Inc. (0001861657) (Filer)

PRER14A - Tharimmune, Inc. (0001861657) (Filer)